BHCM
PLSE icon

Brevan Howard Capital Management’s Pulse Biosciences PLSE Stock Holding History

Brevan Howard Capital Management’s Portfolio PLSE Stock Details PLSE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$263K Buy
+12,164
New +$225K ﹤0.01% 1715
2025
Q3 		– Sell
-14,265
Closed -$215K – 2205
2025
Q2 		$215K Buy
+14,265
New +$237K ﹤0.01% 1686

Other funds holding PLSE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PCM
Portolan Capital Management Boston, Massachusetts $1.88B AUM 115.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
GAM
Griffin Asset Management New York $887M AUM 21.42% 1-Year Est. Return
LP
LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return

Brevan Howard Capital Management's PLSE Position: Q1 2026 in Review

Brevan Howard Capital Management opened a new position in Pulse Biosciences (PLSE) in Q1 2026: 12,164 shares worth $263K. The stake represents ﹤0.01% of the portfolio and ranks #1715 among its holdings. This is a return to the name: Brevan Howard Capital Management previously reported a position in PLSE as recently as Q2 2025.

Brevan Howard Capital Management first reported a position in PLSE in Q2 2025 and has held it in 2 quarters since. 96 funds tracked by Wall St. Rank hold PLSE as of Q1 2026.

  • Brevan Howard Capital Management held 12,164 shares of Pulse Biosciences worth $263K as of Q1 2026.
  • Pulse Biosciences was a new Brevan Howard Capital Management position in Q1 2026.
  • Pulse Biosciences made up ﹤0.01% of Brevan Howard Capital Management's portfolio in Q1 2026, its #1715 holding.
  • Brevan Howard Capital Management first reported a position in Pulse Biosciences in Q2 2025 and has held it in 2 quarters since.
  • 96 funds tracked by Wall St. Rank held Pulse Biosciences as of Q1 2026.

Based on Brevan Howard Capital Management's 13F filing for Q1 2026, filed 15 May 2026.